Document:

Exhibit 4.8

 

 

 

 

 

 

 

 

 

Aethlon
Medical, Inc.

and

_____________, As Warrant Agent

 

Form
of Debt Securities

Warrant Agreement

Dated As Of __________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	1	 

     

    

 

Aethlon Medical Inc. Form
of Debt Securities Warrant Agreement

 

This
Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Aethlon
Medical, Inc., a Nevada corporation (the “Company”), and [●], a [corporation] [national
banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant
agent (the “Warrant Agent”).

 

WHEREAS, the
Company has entered into an indenture dated as of [●] (the “Indenture”), with [●], as trustee
(such trustee, and any successors to such trustee, herein called the “Trustee”), providing for the issuance
from time to time of its debt securities, to be issued in one or more series as provided in the Indenture (the “Debt
Securities”);

 

Whereas,
the Company proposes to sell [If Warrants are sold with other securities —[title of such other securities
being offered] (the “Other Securities”) with] warrant certificates evidencing one or more warrants (the
“Warrants” or, individually, a “Warrant”) representing the right to purchase
[title of Debt Securities purchasable through exercise of Warrants] (the “Warrant Debt Securities”),
such warrant certificates and other warrant certificates issued pursuant to this Agreement being herein called the “Warrant
Certificates”; and

 

Whereas,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in
connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrant Certificates, and in this
Agreement wishes to set forth, among other things, the form and provisions of the Warrant Certificates and the terms and conditions
on which they may be issued, registered, transferred, exchanged, exercised and replaced.

 

Now
Therefore, in consideration of the premises and of the mutual agreements herein contained, the parties hereto agree
as follows:

 

Article
1

ISSUANCE OF WARRANTS AND EXECUTION AND

DELIVERY OF WARRANT CERTIFICATES

 

1.1              
Issuance of Warrants. [If Warrants alone — Upon issuance, each Warrant Certificate shall
evidence one or more Warrants.] [If Other Securities and Warrants — Warrant Certificates will be issued in
connection with the issuance of the Other Securities but shall be separately transferable and each Warrant Certificate shall evidence
one or more Warrants.] Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and
therein, to purchase one Warrant Debt Security. [If Other Securities and Warrants — Warrant Certificates will
be issued with the Other Securities and each Warrant Certificate will evidence [●] Warrants for each [$[●] principal
amount] [[●] shares] of Other Securities issued.]

 

1.2              
Execution and Delivery of Warrant Certificates. Each Warrant Certificate, whenever issued, shall be in registered form
substantially in the form set forth in Exhibit A hereto, shall be dated the date of its countersignature by the Warrant
Agent and may have such letters, numbers, or other marks of identification or designation and such legends or endorsements printed,
lithographed or engraved thereon as the officers of the Company executing the same may approve (execution thereof to be conclusive
evidence of such approval) and as are not inconsistent with the provisions of this Agreement, or as may be required to comply with
any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which
the Warrants may be listed, or to conform to usage. The Warrant Certificates shall be signed on behalf of the Company by any of
its present or future chief executive officers, presidents, senior vice presidents, vice presidents, chief financial officers,
chief legal officers, treasurers, assistant treasurers, controllers, assistant controllers, secretaries or assistant secretaries
under its corporate seal reproduced thereon. Such signatures may be manual or facsimile signatures of such authorized officers
and may be imprinted or otherwise reproduced on the Warrant Certificates. The seal of the Company may be in the form of a facsimile
thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant Certificates.

 

 

 

    	 	2	 

     

    

 

No Warrant Certificate
shall be valid for any purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been
countersigned by the manual signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed
by the Company shall be conclusive evidence that the Warrant Certificate so countersigned has been duly issued hereunder.

 

In case any officer
of the Company who shall have signed any of the Warrant Certificates either manually or by facsimile signature shall cease to be
such officer before the Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent, such Warrant
Certificates may be countersigned and delivered notwithstanding that the person who signed such Warrant Certificates ceased to
be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by such persons as, at the actual
date of the execution of such Warrant Certificate, shall be the proper officers of the Company, although at the date of the execution
of this Agreement any such person was not such officer.

 

The term “holder”
or “holder of a Warrant Certificate” as used herein shall mean any person in whose name at the time any
Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose.

 

1.3              
Issuance of Warrant Certificates. Warrant Certificates evidencing the right to purchase Warrant Debt Securities may
be executed by the Company and delivered to the Warrant Agent upon the execution of this Agreement or from time to time thereafter.
The Warrant Agent shall, upon receipt of Warrant Certificates duly executed on behalf of the Company, countersign such Warrant
Certificates and shall deliver such Warrant Certificates to or upon the order of the Company.

 

Article
2

WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS

 

2.1              
Warrant Price. During the period specified in Section 2.2, each Warrant shall, subject to the terms of this Agreement
and the applicable Warrant Certificate, entitle the holder thereof to purchase the principal amount of Warrant Debt Securities
specified in the applicable Warrant Certificate at an exercise price of [●]% of the principal amount thereof [plus accrued
amortization, if any, of the original issue discount of the Warrant Debt Securities] [plus accrued interest, if any, from the most
recent date from which interest shall have been paid on the Warrant Debt Securities or, if no interest shall have been paid on
the Warrant Debt Securities, from the date of their initial issuance.] [The original issue discount ($[●] for each $1,000
principal amount of Warrant Debt Securities) will be amortized at a [●]% annual rate, computed on a[n] [semi-] annual basis
[using a 360-day year consisting of twelve 30-day months].] Such purchase price for the Warrant Debt Securities is referred to
in this Agreement as the “Warrant Price.

 

2.2              
Duration of Warrants. Each Warrant may be exercised in whole or in part at any time, as specified herein, on or after
[the date thereof] [●] and at or before [●] p.m., [City] time, on [●] or such later date as the Company may designate
by notice to the Warrant Agent and the holders of Warrant Certificates mailed to their addresses as set forth in the record books
of the Warrant Agent (the “Expiration Date”). Each Warrant not exercised at or before [●] p.m.,
[City] time, on the Expiration Date shall become void, and all rights of the holder of the Warrant Certificate evidencing such
Warrant under this Agreement shall cease.

 

 

 

    	 	3	 

     

    

 

2.3              
Exercise of Warrants.

 

(a)               
During the period specified in Section 2.2, the Warrants may be exercised to purchase a whole number of Warrant Debt
Securities in registered form by providing certain information as set forth on the reverse side of the Warrant Certificate and
by paying in full, in lawful money of the United States of America, [in cash or by certified check or official bank check in New
York Clearing House funds] [by bank wire transfer in immediately available funds] the Warrant Price for each Warrant Debt Security
with respect to which a Warrant is being exercised to the Warrant Agent at its corporate trust office, provided that such exercise
is subject to receipt within five business days of such payment by the Warrant Agent of the Warrant Certificate with the form of
election to purchase Warrant Debt Securities set forth on the reverse side of the Warrant Certificate properly completed and duly
executed. The date on which payment in full of the Warrant Price is received by the Warrant Agent shall, subject to receipt of
the Warrant Certificate as aforesaid, be deemed to be the date on which the Warrant is exercised; provided, however, that if, at
the date of receipt of such Warrant Certificates and payment in full of the Warrant Price, the transfer books for the Warrant Debt
Securities purchasable upon the exercise of such Warrants shall be closed, no such receipt of such Warrant Certificates and no
such payment of such Warrant Price shall be effective to constitute the person so designated to be named as the holder of record
of such Warrant Debt Securities on such date, but shall be effective to constitute such person as the holder of record of such
Warrant Debt Securities for all purposes at the opening of business on the next succeeding day on which the transfer books for
the Warrant Debt Securities purchasable upon the exercise of such Warrants shall be opened, and the certificates for the Warrant
Debt Securities in respect of which such Warrants are then exercised shall be issuable as of the date on such next succeeding day
on which the transfer books shall next be opened, and until such date the Company shall be under no duty to deliver any certificate
for such Warrant Debt Securities. The Warrant Agent shall deposit all funds received by it in payment of the Warrant Price in an
account of the Company maintained with it and shall advise the Company by telephone at the end of each day on which a payment for
the exercise of Warrants is received of the amount so deposited to its account. The Warrant Agent shall promptly confirm such telephone
advice to the Company in writing.

 

(b)              
The Warrant Agent shall, from time to time, as promptly as practicable, advise the Company of (i) the number of Warrant
Debt Securities with respect to which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates
evidencing such Warrants with respect to delivery of the Warrant Debt Securities to which such holder is entitled upon such exercise,
(iii) delivery of Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Debt Securities
after such exercise, and (iv) such other information as the Company or the Trustee shall reasonably require.

 

(c)               
As soon as practicable after the exercise of any Warrant, the Company shall issue pursuant to the Indenture, in authorized
denominations, to or upon the order of the holder of the Warrant Certificate evidencing such Warrant the Warrant Debt Securities
to which such holder is entitled, in fully registered form, registered in such name or names as may be directed by such holder.
If fewer than all of the Warrants evidenced by such Warrant Certificate are exercised, the Company shall execute, and an authorized
officer of the Warrant Agent shall manually countersign and deliver, a new Warrant Certificate evidencing Warrants for the number
of Warrant Debt Securities remaining unexercised.

 

(d)              
The Company shall not be required to pay any stamp or other tax or other governmental charge required to be paid in
connection with any transfer involved in the issue of the Warrant Debt Securities, and in the event that any such transfer is involved,
the Company shall not be required to issue or deliver any Warrant Debt Securities until such tax or other charge shall have been
paid or it has been established to the Company’s satisfaction that no such tax or other charge is due.

 

(e)               
Prior to the issuance of any Warrants there shall have been reserved, and the Company shall at all times through the
Expiration Date keep reserved, out of its authorized but unissued Warrant Debt Securities, a number of shares sufficient to provide
for the exercise of the Warrants.

 

 

 

    	 	4	 

     

    

 

Article
3

OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS OF

WARRANT CERTIFICATES

 

3.1              
No Rights as Holder of Warrant Debt Securities Conferred by Warrants or Warrant Certificates. No Warrant Certificate
or Warrant evidenced thereby shall entitle the holder thereof to any of the rights of a holder of Warrant Debt Securities, including,
without limitation, the right to receive the payment of principal of (or premium, if any) or interest, if any, on the Warrant Debt
Securities or to enforce any of the covenants in the Indenture.

 

3.2              
Lost, Stolen, Mutilated or Destroyed Warrant Certificates. Upon receipt by the Warrant Agent of evidence reasonably
satisfactory to it and the Company of the ownership of and the loss, theft, destruction or mutilation of any Warrant Certificate
and/or indemnity reasonably satisfactory to the Warrant Agent and the Company and, in the case of mutilation, upon surrender of
the mutilated Warrant Certificate to the Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant
Agent that such Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an authorized officer
of the Warrant Agent shall manually countersign and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated
Warrant Certificate, a new Warrant Certificate of the same tenor and evidencing Warrants for a like principal amount of Warrant
Debt Securities. Upon the issuance of any new Warrant Certificate under this Section 3.2, the Company may require the payment of
a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including
the fees and expenses of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered
pursuant to this Section 3.2 in lieu of any lost, stolen or destroyed Warrant Certificate shall represent an additional contractual
obligation of the Company, whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by
anyone, and shall be entitled to the benefits of this Agreement equally and proportionately with any and all other Warrant Certificates
duly executed and delivered hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to the extent lawful)
all other rights and remedies with respect to the replacement of mutilated, lost, stolen or destroyed Warrant Certificates.

 

3.3              
Holder of Warrant Certificate May Enforce Rights. Notwithstanding any of the provisions of this Agreement, any holder
of a Warrant Certificate, without the consent of the Warrant Agent, , the Trustee, the holder of any Warrant Debt Securities or
the holder of any other Warrant Certificate, may, in such holder’s own behalf and for such holder’s own benefit, enforce,
and may institute and maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect
of, such holder’s right to exercise the Warrants evidenced by such holder’s Warrant Certificate in the manner provided
in such holder’s Warrant Certificates and in this Agreement.

 

3.4              
Merger, Sale, Conveyance or Lease. In case of (a) any share exchange, merger or similar transaction of the Company with
or into another person or entity (other than a share exchange, merger or similar transaction in which the Company is the acquiring
or surviving corporation) or (b) the sale, exchange, lease, transfer or other disposition of all or substantially all of the properties
and assets of the Company as an entirety (in any such case, a “Reorganization Event”), then, as a condition
of such Reorganization Event, lawful provisions shall be made, and duly executed documents evidencing the same from the Company’s
successor shall be delivered to the holders of the Warrants, so that such successor shall succeed to and be substituted for the
Company, and assume all the Company’s obligations under, this Agreement and the Warrants. The Company shall thereupon be
relieved of any further obligation hereunder or under the Warrants, and the Company as the predecessor corporation may thereupon
or at any time thereafter be dissolved, wound up or liquidated. Such successor or assuming entity thereupon may cause to be signed,
and may issue either in its own name or in the name of the Company, any or all of the Warrants issuable hereunder which heretofore
shall not have been signed by the Company, and may execute and deliver securities in its own name, in fulfillment of its obligations
to deliver Warrant Debt Securities upon exercise of the Warrants. All the Warrants so issued shall in all respects have the same
legal rank and benefit under this Agreement as the Warrants theretofore or thereafter issued in accordance with the terms of this
Agreement as though all of such Warrants had been issued at the date of the execution hereof. In any case of any such Reorganization
Event, such changes in phraseology and form (but not in substance) may be made in the Warrants thereafter to be issued as may be
appropriate. The Warrant Agent may receive a written opinion of legal counsel as conclusive evidence that any such Reorganization
Event complies with the provisions of this Section 3.4.

 

 

 

    	 	5	 

     

    

 

3.5              
Notice to Warrantholders. In case the Company shall (a) effect any Reorganization Event or (b) make any distribution
on or in respect of the [title of Warrant Debt Securities] in connection with the dissolution, liquidation or winding up of the
Company, then the Company shall mail to each holder of Warrants at such holder’s address as it shall appear on the books
of the Warrant Agent, at least ten days prior to the applicable date hereinafter specified, a notice stating the date on which
such Reorganization Event, dissolution, liquidation or winding up is expected to become effective, and the date as of which it
is expected that holders of [title of Warrant Debt Securities] of record shall be entitled to exchange their shares of [title of
Warrant Debt Securities] for securities or other property deliverable upon such Reorganization Event, dissolution, liquidation
or winding up. No failure to mail such notice nor any defect therein or in the mailing thereof shall affect any such transaction.

 

Article
4

EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES

 

4.1              
Exchange and Transfer of Warrant Certificates. Upon surrender at the corporate trust office of the Warrant Agent, Warrant
Certificates evidencing Warrants may be exchanged for Warrant Certificates in other denominations evidencing such Warrants or the
transfer thereof may be registered in whole or in part; provided that such other Warrant Certificates evidence Warrants for the
same aggregate principal amount of Warrant Debt Securities as the Warrant Certificates so surrendered. The Warrant Agent shall
keep, at its corporate trust office, books in which, subject to such reasonable regulations as it may prescribe, it shall register
Warrant Certificates and exchanges and transfers of outstanding Warrant Certificates, upon surrender of the Warrant Certificates
to the Warrant Agent at its corporate trust office for exchange or registration of transfer, properly endorsed or accompanied by
appropriate instruments of registration of transfer and written instructions for transfer, all in form satisfactory to the Company
and the Warrant Agent. No service charge shall be made for any exchange or registration of transfer of Warrant Certificates, but
the Company may require payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be imposed
in connection with any such exchange or registration of transfer. Whenever any Warrant Certificates are so surrendered for exchange
or registration of transfer, an authorized officer of the Warrant Agent shall manually countersign and deliver to the person or
persons entitled thereto a Warrant Certificate or Warrant Certificates duly authorized and executed by the Company, as so requested.
The Warrant Agent shall not be required to effect any exchange or registration of transfer which will result in the issuance of
a Warrant Certificate evidencing a Warrant for a fraction of a Warrant Debt Security or a number of Warrants for a whole number
of Warrant Debt Securities and a fraction of a Warrant Debt Security. All Warrant Certificates issued upon any exchange or registration
of transfer of Warrant Certificates shall be the valid obligations of the Company, evidencing the same obligations and entitled
to the same benefits under this Agreement as the Warrant Certificate surrendered for such exchange or registration of transfer.

 

4.2              
Treatment of Holders of Warrant Certificates. The Company, the Warrant Agent and all other persons may treat the registered
holder of a Warrant Certificate as the absolute owner thereof for any purpose and as the person entitled to exercise the rights
represented by the Warrants evidenced thereby, any notice to the contrary notwithstanding.

 

4.3              
Cancellation of Warrant Certificates. Any Warrant Certificate surrendered for exchange, registration of transfer or
exercise of the Warrants evidenced thereby shall, if surrendered to the Company, be delivered to the Warrant Agent and all Warrant
Certificates surrendered or so delivered to the Warrant Agent shall be promptly canceled by the Warrant Agent and shall not be
reissued and, except as expressly permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor
or in lieu thereof. The Warrant Agent shall deliver to the Company from time to time or otherwise dispose of canceled Warrant Certificates
in a manner satisfactory to the Company.

 

 

 

    	 	6	 

     

    

 

Article
5

CONCERNING THE WARRANT AGENT

 

5.1              
Warrant Agent. The Company hereby appoints [●] as Warrant Agent of the Company in respect of the Warrants and
the Warrant Certificates upon the terms and subject to the conditions herein set forth, and [●] hereby accepts such appointment.
The Warrant Agent shall have the powers and authority granted to and conferred upon it in the Warrant Certificates and hereby and
such further powers and authority to act on behalf of the Company as the Company may hereafter grant to or confer upon it. All
of the terms and provisions with respect to such powers and authority contained in the Warrant Certificates are subject to and
governed by the terms and provisions hereof.

 

5.2              
Conditions of Warrant Agent’s Obligations. The Warrant Agent accepts its obligations herein set forth upon the
terms and conditions hereof, including the following to all of which the Company agrees and to all of which the rights hereunder
of the holders from time to time of the Warrant Certificates shall be subject:

 

(a)               
Compensation and Indemnification. The Company agrees promptly to pay the Warrant Agent the compensation to be agreed
upon with the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket
expenses (including reasonable counsel fees) incurred without negligence, bad faith or willful misconduct by the Warrant Agent
in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent
for, and to hold it harmless against, any loss, liability or expense incurred without negligence, bad faith or willful misconduct
on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including the reasonable
costs and expenses of defending against any claim of such liability.

 

(b)              
Agent for the Company. In acting under this Agreement and in connection with the Warrant Certificates, the Warrant Agent
is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with any
of the holders of Warrant Certificates or beneficial owners of Warrants.

 

(c)               
Counsel. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and
the written advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered
or omitted by it hereunder in good faith and in accordance with the advice of such counsel.

 

(d)              
Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or
omitted by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other
paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.

 

(e)               
Certain Transactions. The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire
any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to
the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with the Company
and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Debt Securities or other obligations
of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this Agreement shall be deemed to prevent the
Warrant Agent from acting as trustee under any indenture to which the Company is a party, including, without limitation, as Trustee
under the Indenture.

 

 

 

    	 	7	 

     

    

 

(f)                
No Liability for Interest. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for interest
on any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.

 

(g)               
No Liability for Invalidity. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement
or any of the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon).

 

(h)              
No Responsibility for Representations. The Warrant Agent shall not be responsible for any of the recitals or representations
herein or in the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon), all of which are made
solely by the Company.

 

(i)                
No Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant
Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates
against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which may tend to involve
it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it.
The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant
Certificates authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application
by the Company of the proceeds of the Warrant Certificates. The Warrant Agent shall have no duty or responsibility in case of any
default by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in
the case of the receipt of any written demand from a holder of a Warrant Certificate with respect to such default, including, without
limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law
or otherwise or, except as provided in Section 6.2 hereof, to make any demand upon the Company.

 

5.3              
Resignation, Removal and Appointment of Successors.

 

(a)               
The Company agrees, for the benefit of the holders from time to time of the Warrant Certificates, that there shall at
all times be a Warrant Agent hereunder until all the Warrants have been exercised or are no longer exercisable.

 

(b)              
The Warrant Agent may at any time resign as agent by giving written notice to the Company of such intention on its part,
specifying the date on which its desired resignation shall become effective; provided that such date shall not be less than three
months after the date on which such notice is given unless the Company otherwise agrees. The Warrant Agent hereunder may be removed
at any time by the filing with it of an instrument in writing signed by or on behalf of the Company and specifying such removal
and the intended date when it shall become effective. Such resignation or removal shall take effect upon the appointment by the
Company, as hereinafter provided, of a successor Warrant Agent (which shall be a bank or trust company authorized under the laws
of the jurisdiction of its organization to exercise corporate trust powers) and the acceptance of such appointment by such successor
Warrant Agent. The obligation of the Company under Section 5.2(a) shall continue to the extent set forth therein notwithstanding
the resignation or removal of the Warrant Agent.

 

(c)               
In case at any time the Warrant Agent shall resign, or shall be removed, or shall become incapable of acting, or shall
be adjudged a bankrupt or insolvent, or shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter
constituted, or under any other applicable Federal or state bankruptcy, insolvency or similar law or shall consent to the appointment
of or taking possession by a receiver, custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the
Warrant Agent or its property or affairs, or shall make an assignment for the benefit of creditors, or shall admit in writing its
inability to pay its debts generally as they become due, or shall take corporate action in furtherance of any such action, or a
decree or order for relief by a court having jurisdiction in the premises shall have been entered in respect of the Warrant Agent
in an involuntary case under the Federal bankruptcy laws, as now or hereafter constituted, or any other applicable Federal or state
bankruptcy, insolvency or similar law, or a decree or order by a court having jurisdiction in the premises shall have been entered
for the appointment of a receiver, custodian, liquidator, assignee, trustee, sequestrator (or similar official) of the Warrant
Agent or of its property or affairs, or any public officer shall take charge or control of the Warrant Agent or of its property
or affairs for the purpose of rehabilitation, conservation, winding up or liquidation, a successor Warrant Agent, qualified as
aforesaid, shall be appointed by the Company by an instrument in writing, filed with the successor Warrant Agent. Upon the appointment
as aforesaid of a successor Warrant Agent and acceptance by the successor Warrant Agent of such appointment, the Warrant Agent
shall cease to be Warrant Agent hereunder.

 

 

 

    	 	8	 

     

    

 

(d)              
Any successor Warrant Agent appointed hereunder shall execute, acknowledge and deliver to its predecessor and to the
Company an instrument accepting such appointment hereunder, and thereupon such successor Warrant Agent, without any further act,
deed or conveyance, shall become vested with all the authority, rights, powers, trusts, immunities, duties and obligations of such
predecessor with like effect as if originally named as Warrant Agent hereunder, and such predecessor, upon payment of its charges
and disbursements then unpaid, shall thereupon become obligated to transfer, deliver and pay over, and such successor Warrant Agent
shall be entitled to receive, all monies, securities and other property on deposit with or held by such predecessor, as Warrant
Agent hereunder.

 

(e)               
Any corporation into which the Warrant Agent hereunder may be merged or converted or any corporation with which the
Warrant Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Warrant
Agent shall be a party, or any corporation to which the Warrant Agent shall sell or otherwise transfer all or substantially all
the assets and business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant
Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto.

 

Article
6

MISCELLANEOUS

 

6.1              
Amendment. This Agreement may be amended by the parties hereto, without the consent of the holder of any Warrant Certificate,
for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein, or
making any other provisions with respect to matters or questions arising under this Agreement as the Company and the Warrant Agent
may deem necessary or desirable; provided that such action shall not materially adversely affect the interests of the holders of
the Warrant Certificates.

 

6.2              
Notices and Demands to the Company and Warrant Agent. If the Warrant Agent shall receive any notice or demand addressed
to the Company by the holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent
shall promptly forward such notice or demand to the Company.

 

6.3              
Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed
to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall
be addressed to Aethlon Medical, Inc., 9635 Granite Ridge Drive, Suite 100, San Diego, California 92123, Attention: [●] (or
such other address as shall be specified in writing by the Warrant Agent or by the Company).

 

6.4              
Governing Law. This Agreement and each Warrant Certificate issued hereunder shall be governed by and construed in accordance
with the laws of the State of New York.

 

6.5              
Delivery of Prospectus. The Company shall furnish to the Warrant Agent sufficient copies of a prospectus meeting the
requirements of the Securities Act of 1933, as amended, relating to the Warrant Debt Securities deliverable upon exercise of the
Warrants (the “Prospectus”), and the Warrant Agent agrees that upon the exercise of any Warrant, the
Warrant Agent will deliver to the holder of the Warrant Certificate evidencing such Warrant, prior to or concurrently with the
delivery of the Warrant Debt Securities issued upon such exercise, a Prospectus. The Warrant Agent shall not, by reason of any
such delivery, assume any responsibility for the accuracy or adequacy of such Prospectus.

 

 

 

    	 	9	 

     

    

 

6.6              
Obtaining of Governmental Approvals. The Company will from time to time take all action which may be necessary to obtain
and keep effective any and all permits, consents and approvals of governmental agencies and authorities and securities act filings
under United States Federal and state laws (including without limitation a registration statement in respect of the Warrants and
Warrant Debt Securities under the Securities Act of 1933, as amended), which may be or become requisite in connection with the
issuance, sale, transfer, and delivery of the Warrant Debt Securities issued upon exercise of the Warrants, the issuance, sale,
transfer and delivery of the Warrants or upon the expiration of the period during which the Warrants are exercisable.

 

6.7              
Persons Having Rights Under the Agreement. Nothing in this Agreement shall give to any person other than the Company,
the Warrant Agent and the holders of the Warrant Certificates any right, remedy or claim under or by reason of this Agreement.

 

6.8              
Headings. The descriptive headings of the several Articles and Sections of this Agreement are inserted for convenience
only and shall not control or affect the meaning or construction of any of the provisions hereof.

 

6.9              
Counterparts. This Agreement may be executed in any number of counterparts, each of which as so executed shall be deemed
to be an original, but such counterparts shall together constitute but one and the same instrument.

 

6.10          
Inspection of Agreement. A copy of this Agreement shall be available at all reasonable times at the principal corporate
trust office of the Warrant Agent for inspection by the holder of any Warrant Certificate. The Warrant Agent may require such holder
to submit such holder’s Warrant Certificate for inspection by it.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	10	 

     

    

 

In
Witness Whereof, the parties hereto have caused this Agreement to be duly executed as of the day and year first above
written.

 

	 	Aethlon Medical, Inc., as Company
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	ATTEST:	 
	 	 	 
	 	 	 
	 	 
	 	
         

         

        COUNTERSIGNED

         

        [●], as Warrant Agent

	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	ATTEST:	 
	 	 	 
	 	 	 
	 	 	 

 

 

 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

Exhibit
A

 

FORM OF WARRANT CERTIFICATE

[FACE OF WARRANT CERTIFICATE]

 

	 	 	 
	 	 	 
	 	 
	[Form of Legend if Warrants are not immediately exercisable.]	 	[Prior to [●], Warrants evidenced by this Warrant Certificate cannot be exercised.]

 

EXERCISABLE ONLY IF COUNTERSIGNED BY THE
WARRANT AGENT AS PROVIDED HEREIN

 

VOID AFTER [●] P.M., [City] time,
ON [●].

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	12	 

     

    

 

AETHLON MEDICAL, INC.

WARRANT CERTIFICATE REPRESENTING

WARRANTS TO PURCHASE

[TITLE OF WARRANT DEBT SECURITIES]

 

	No. [●]	[●] Warrants

 

This certifies that [●] or registered
assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling such owner to purchase, at any
time [after [●] p.m., [City] time, [on [●] and] on or before [●] p.m., [City] time, on [●], $[●]
principal amount of [TITLE OF WARRANT DEBT SECURITIES] (the “Warrant Debt Securities”), of Aethlon Medical,
Inc. (the “Company”) issued or to be issued under the Indenture (as hereinafter defined), on the following
basis: during the period from [●], through and including [●], each Warrant shall entitle the Holder thereof, subject
to the provisions of this Agreement, to purchase the principal amount of Warrant Debt Securities stated in the Warrant Certificate
at the warrant price (the “Warrant Price”) of [●]% of the principal amount thereof [plus accrued
amortization, if any, of the original issue discount of the Warrant Debt Securities] [plus accrued interest, if any, from the
most recent date from which interest shall have been paid on the Warrant Debt Securities or, if no interest shall have been paid
on the Warrant Debt Securities, from the date of their original issuance]. [The original issue discount ($[●] for each $1,000
principal amount of Warrant Debt Securities) will be amortized at a [●]% annual rate, computed on a[n] [semi-]annual basis
[using a 360-day year consisting of twelve 30-day months]. The Holder may exercise the Warrants evidenced hereby by providing
certain information set forth on the back hereof and by paying in full, in lawful money of the United States of America, [in cash
or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available
funds], the Warrant Price for each Warrant Debt Security with respect to which this Warrant is exercised to the Warrant Agent
(as hereinafter defined) and by surrendering this Warrant Certificate, with the purchase form on the back hereof duly executed,
at the corporate trust office of [name of Warrant Agent], or its successor as warrant agent (the “Warrant Agent”),
which is, on the date hereof, at the address specified on the reverse hereof, and upon compliance with and subject to the conditions
set forth herein and in the Warrant Agreement (as hereinafter defined).

 

The term “Holder”
as used herein shall mean the person in whose name at the time this Warrant Certificate shall be registered upon the books to be
maintained by the Warrant Agent for that purpose pursuant to Section 4 of the Warrant Agreement.

 

The Warrants evidenced
by this Warrant Certificate may be exercised to purchase Warrant Debt Securities in the principal amount of $1,000 or any integral
multiple thereof in registered form. Upon any exercise of fewer than all of the Warrants evidenced by this Warrant Certificate,
there shall be issued to the Holder hereof a new Warrant Certificate evidencing Warrants for the aggregate principal amount of
Warrant Debt Securities remaining unexercised.

 

This Warrant Certificate
is issued under and in accordance with the Warrant Agreement dated as of [●] (the “Warrant Agreement”),
between the Company and the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to all
of which terms and provisions the Holder of this Warrant Certificate consents by acceptance hereof. Copies of the Warrant Agreement
are on file at the above-mentioned office of the Warrant Agent.

 

The Warrant Debt Securities to be issued
and delivered upon the exercise of Warrants evidenced by this Warrant Certificate will be issued under and in accordance with an
Indenture, dated as of [●] (the “Indenture”), between the Company and [●], as trustee (such
trustee, and any successors to such trustee, the “Trustee”)] and will be subject to the terms and provisions
contained in the Warrant Debt Securities and in the Indenture. Copies of the Indenture, including the form of the Warrant Debt
Securities, are on file at the corporate trust office of the Trustee.

 

Transfer of this Warrant
Certificate may be registered when this Warrant Certificate is surrendered at the corporate trust office of the Warrant Agent by
the registered owner or such owner’s assigns, in the manner and subject to the limitations provided in the Warrant Agreement.

 

 

 

 

    	 	13	 

     

    

 

After countersignature
by the Warrant Agent and prior to the expiration of this Warrant Certificate, this Warrant Certificate may be exchanged at the
corporate trust office of the Warrant Agent for Warrant Certificates representing Warrants for the same aggregate principal amount
of Warrant Debt Securities.

 

This Warrant Certificate
shall not entitle the Holder hereof to any of the rights of a holder of the Warrant Debt Securities, including, without limitation,
the right to receive payments of principal of (and premium, if any) or interest, if any, on the Warrant Debt Securities or to enforce
any of the covenants of the Indenture.

Reference is hereby made
to the further provisions of this Warrant Certificate set forth on the reverse hereof, which further provisions shall for all purposes
have the same effect as if set forth at this place.

 

This Warrant Certificate
shall not be valid or obligatory for any purpose until countersigned by the Warrant Agent.

 

In
Witness Whereof, the Company has caused this Warrant to be executed in its name and on its behalf by the facsimile signatures
of its duly authorized officers.

 

 

	 	Dated:	_________________
	 	
         

         
	 
	 	Aethlon Medical, Inc., as Company
	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	ATTEST:	 
	 	 	 
	 	 	 
	 	 
	 	
         

         

        COUNTERSIGNED

         

        [●], as Warrant Agent

	 	 	 
	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	 	 
	 	ATTEST:	 
	 	 	 
	 	 	 
	 	 	 

 

 

 

 

    	 	14	 

     

    

 

[REVERSE OF WARRANT CERTIFICATE]

 

(Instructions for Exercise of Warrant)

 

To exercise any Warrants
evidenced hereby for Warrant Debt Securities (as hereinafter defined), the Holder must pay, in lawful money of the United States
of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately
available funds], the Warrant Price in full for Warrants exercised, to [●] [address of Warrant Agent], Attention: [●],
which payment must specify the name of the Holder and the number of Warrants exercised by such Holder. In addition, the Holder
must complete the information required below and present this Warrant Certificate in person or by mail (certified or registered
mail is recommended) to the Warrant Agent at the appropriate address set forth above. This Warrant Certificate, completed and duly
executed, must be received by the Warrant Agent within five business days of the payment.

 

(To be executed upon exercise of Warrants)

 

The undersigned hereby
irrevocably elects to exercise ______ Warrants, evidenced by this Warrant Certificate, to purchase _______ $[●] principal
amount of the [TITLE OF WARRANT DEBT SECURITIES] (the “Warrant Debt Securities”), of Aethlon Medical,
Inc. and represents that the undersigned has tendered payment for such Warrant Debt Securities, in lawful money of the United States
of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately
available funds], to the order of Aethlon Medical, Inc., c/o [insert name and address of Warrant Agent], in the amount of $_________
in accordance with the terms hereof. The undersigned requests that said principal amount of Warrant Debt Securities be in fully
registered form in the authorized denominations, registered in such names and delivered all as specified in accordance with the
instructions set forth below.

 

If the number of Warrants
exercised is less than all of the Warrants evidenced hereby, the undersigned requests that a new Warrant Certificate evidencing
the Warrants for the aggregate principal amount of Warrant Debt Securities remaining unexercised be issued and delivered to the
undersigned unless otherwise specified in the instructions below.

 

	Dated:	 	 	Name:	 
	 	 	 	 	Please Print
	Address:	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	(Insert Social Security or Other Identifying Number of Holder)	 	 	 
	 	 	 	 	 
	Signature Guaranteed:                                      	 	 
	Signature	 	 	 

 

(Signature must conform in all respects
to name of holder as specified on the face of this Warrant Certificate and must bear a signature guarantee by a FINRA member firm).

 

This Warrant may be exercised at the following
addresses: By hand at:

 

[●]

 

By mail at:

 

[Instructions as to form and delivery of
Warrant Debt Securities and, if applicable, Warrant Certificates evidencing Warrants for the number of Warrant Debt Securities
remaining unexercised—complete as appropriate.]

 

 

 

    	 	15	 

     

    

 

 

ASSIGNMENT

 

[Form of assignment to be executed if Warrant
Holder desires to transfer Warrant]

 

For
Value Received, ______________ hereby sells, assigns and transfers unto:

 

 

	(Please print name and address
including zip code)	 	Please print Social Security or other identifying number

 

 

the right represented by the within Warrant
to purchase ________ aggregate principal amount of [Title of Warrant Debt Securities] of Aethlon Medical, Inc. to which the within
Warrant relates and appoints ____________________ attorney to transfer such right on the books of the Warrant Agent with full power
of substitution in the premises.

 

 

	Dated:	 	 	Name:	 
	 	 	 	 	Please Print
	 	 	 	 	 
	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	Signature Guaranteed:                                      	 	 
	Signature	 	 	 

 

 

 

 

 

 

 

 

 

 

 

    	 	16EX-10.1

 Exhibit 10.1 
  

 
 May 25, 2019 

Mr. David Meredith 
 [Address] 

Re:    Terms of Employment 

Dear David: 
 This letter agreement (this
“Agreement”) will set forth the terms of your employment relationship with Everbridge, Inc., and/or any present or future parent, subsidiary or affiliate thereof (collectively, the “Company”). This Agreement hereby
supersedes any and all previous agreements relating to your employment relationship with the Company. The terms of your position with the Company are as set forth below and will be effective only upon, and subject to, the signing of this Agreement
and any other agreements or documentation required hereunder, by you and the Company as of the Commencement Date referenced below. Your new role shall commence on July 15, 2019 (the “Commencement Date”), unless you and the
Company mutually agree on an alternative date. 
 1.    Employment. 

(a)    Title, Term and Duties. Subject to the terms and conditions of this Agreement, the Company will employ you,
and you will be employed by the Company, as Chief Executive Officer (“CEO”), reporting to the Board of Directors of the Company (the “Board”) through Jaime Ellertson, Chairman or his direct designate, and such additional
position or positions as the Board may determine in its sole discretion. The term of your employment shall be three years ending on the third anniversary of the Commencement Date, unless earlier terminated in accordance with the terms hereof. On the
third anniversary of the Commencement Date and on each anniversary thereafter, your employment hereunder shall be automatically extended for a one-year period, unless earlier terminated in accordance with the
terms hereof, and unless you or the Company shall have given written notice to the other party of a desire that such automatic extension not occur, which notice was given no later than sixty (60) days prior to the relevant anniversary of the
Commencement Date. You shall do and perform all services, acts or things necessary or advisable to manage and conduct the business of the Company and which are normally associated with your position and as further described in Schedule 1 attached
hereto. As long as you continue in your role as CEO, you also will serve as a member of Board. The effective date of your joining the Board will be the date of the Board’s approval of the appointment. 

(b)    Full Time Best Efforts. For so long as you are employed hereunder, you will devote substantially all of your
business time and energies to the business and affairs of the Company, and shall at all times faithfully, industriously and to the best of your ability, experience and talent, perform all of your duties and responsibilities hereunder. In furtherance
of, and not in limitation of the foregoing, during the term of this Agreement, you further agree that you shall not render commercial or professional services of any nature, including as a founder, advisor, or a member of a

 
board of directors, to any person or organization, whether or not for compensation, if such services would materially interfere with your duties under this Agreement, without the prior approval
of the Chairman in his sole discretion; provided, however, that nothing contained in this Section 1(c) will be deemed to prevent or limit your right to (i) serve on one for-profit board of directors
or advisory board to companies that do not compete with the Company on your own personal time, unless otherwise agreed by the Board, (ii) manage your personal investments on your own personal time or (iii) participate in religious,
charitable or civic organizations in any capacity on your own personal time. 
 (c)    Location. Unless the
parties hereto otherwise agree in writing, during the term of this Agreement, you shall perform the services required to be performed pursuant to this Agreement at the Company’s Burlington, Massachusetts offices. In addition, the Company may,
from time to time require you to travel temporarily to other locations in connection with the Company’s business. 

2.    Compensation. During the term of your employment with the Company, the Company will pay you the following
compensation: 
 (a)    Salary. As of the Commencement Date, you will be paid an annual salary of Four Hundred
and Fifty Thousand Dollars ($450,000.00), as may be increased from time to time as part of the Company’s normal salary review process (the “Salary”). The Salary shall be prorated for any partial year of employment on the basis
of a 365-day year. Your Salary will be subject to standard payroll deductions and withholdings, and payable in accordance with the Company’s standard payroll practice as it exists from time to time. 

(b)    Expenses. During the term of your employment, the Company shall reimburse you for all reasonable and
documented expenses incurred by you in the performance of your duties, under this Agreement in accordance with Company policy. 

(c)    Annual Performance Bonus. You will be eligible to earn an annual performance bonus at the conclusion of each
year of employment with the Company (the “Annual Bonus”). The amount, award and timing of the payment of the Annual Bonus shall be set forth in a Company Management Incentive Plan, established each year by the Board, in its discretion or
absent the establishment of such Company Management Incentive Plan for any year of your employment by a separate agreement between the Company and you. The Company’s Management Incentive Plan for calendar year 2019 is set forth on Exhibit A
attached hereto and for 2019, your target is Three Hundred and Twenty-Five Thousand Dollars ($325,000). Company Management Incentive Plans, if any, for subsequent years, shall be provided to you by the Chairman. The Annual Bonus payable for calendar
year 2019 shall not be prorated based on your Commencement Date. 
 (d)    Signing Bonus. You will be paid a
signing bonus (the “Signing Bonus”) of One Hundred Thousand Dollars ($100,000) within thirty (30) days of the execution of this Agreement. If you do not commence employment with the Company for any reason or you voluntarily terminate,
which shall not include termination for Good Reason, your employment with the Company on or before twelve (12) months from the payment date, you will be responsible for promptly reimbursing the Company for the full amount of the Signing Bonus.

  
 2 

 (e)    Market Adjustment. You will receive a market adjustment
payment (the “Market Adjustment Payment”) of One Hundred and Forty-Five Thousand Dollars ($145,000.00) to assist you with the higher cost of living in the greater Boston area. This one-time Market
Adjustment Payment will be made within ten (10) days after the Commencement Date. If you voluntarily terminate your employment with the Company, other than for Good Reason, on or before twelve (12) months from the payment date, you will be
responsible for promptly reimbursing the Company for the full amount of the Market Adjustment Payment. 

(f)    Restricted Stock Units and Performance Stock Units. Effective July 1, 2019, you will be granted 100,000
Restricted Stock Units (RSUs) and 100,000 Performance Stock Units (PSUs) under the Company’s 2016 Equity Incentive Plan (the “Equity Plan”). As an additional incentive, the Company will provide an additional grant in July 2020
of 15,000 RSUs and 15,000 PSUs if the Company has achieved cumulatively 95% or greater of its quarterly plan for each of your first four quarters as CEO. The RSUs will vest over three years at 33.3% per year, starting on the first anniversary of the
last day of the month in which the Commencement Date occurs, provided that, (i) there has not been a termination of Continuous Service (as defined in the Company’s 2016 Equity Incentive Plan) as of each such date and (ii) if this
Agreement is not renewed for at least one year after the expiration of the initial three-year term, then this Agreement shall be automatically extended to terminate on the third vesting date of the initial 100,000 RSU grant. The PSUs will vest
according to the PSU vesting schedule included as Exhibit B. If there is a Change in Control (as defined in the Equity Plan) during the initial three-year employment term, then the vesting of any of the foregoing RSUs and PSUs shall be accelerated
as follows: i) for the percentage of shares equal to the number of months of full-time employment as of the date of employment termination divided by thirty six (i.e., number of months of employment divided by 36), as well as, ii) the additional
amount of 50% of all of your unvested (as of the date of termination of employment after the acceleration granted in (i) above), the RSUs and PSUs shall vest in full. In addition, in the event that, within twelve (12) months following a
Change in Control (as defined in the Equity Plan), there is an Involuntary Termination of Service (as defined in the Equity Plan) or you resign for Good Reason (as defined in Section 3(f) below), then any RSUs and PSUs that remain unvested as
of such termination date will vest as of such termination date, subject to the provisions of, and as more fully described in, the applicable PSU or RSU Grant Notice. 

(g)    Employee Benefits. As an employee of the Company, you will be eligible to participate in such
Company-sponsored benefits and programs as are made generally available to other employees of the Company. This includes paying for your portion of healthcare coverage and same 401(k) match as other Company employees. You will receive the same cell
phone stipend as other Everbridge executives. In addition, you will be entitled to (i) annually accrue vacation and/or sick time in accordance with the Company’s vacation policy at a rate of 25 days annually. As part of the SMT benefit
package you will be eligible for business class travel for trips when a flight exceeds 4 hours elapsed time. The Company reserves the right to change or eliminate any benefit plans at any time, upon notice to you. 

3.    Separation Benefits. You shall be entitled to receive separation benefits upon termination of employment only
as set forth in this Section 3; provided, however, that in the event you are entitled to any severance pay under a Company-sponsored severance pay plan, any such severance pay to which you are entitled under such severance pay plan shall
reduce the amount of severance pay to which you are entitled pursuant to this Section 3. In 

  
 3 

 
all cases, upon termination of employment you will receive payment for all salary and unused vacation accrued as of the date of your termination of employment, and your benefits will be continued
under the Company’s then existing benefit plans and policies in accordance with such plans and policies in effect on the date of termination and in accordance with applicable law. In furtherance of, and not in limitation of the foregoing, but
without duplication, during the period wherein which you shall be receiving Separation Payments in accordance with the provisions of Section 3(d) hereof (the “Severance Period”), then the Company shall, at its election, either
(i) continue to pay for your health benefits under the Company’s sponsored health care program in which you were enrolled and eligible to receive benefits prior to your termination of employment, or (ii) pay for your health coverage
under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), in each case, for the Severance Period, when such premiums are due and owing. 

(a)    Voluntary Resignation. If you voluntarily elect to terminate your employment with the Company (other than
under the circumstances described in Section 3(c) below), you shall not be entitled to any separation benefits. 

(b)    Termination for Cause. If the Company or its successor terminates your employment for Cause (as defined
below) then you shall not be entitled to receive any separation benefits. 
 (c)    Termination for Death or
Disability. If your employment with the Company is terminated by reason of death or disability, then, as a severance benefit, the Company shall continue to pay one-twelfth (1/12th) of your Salary for a
period of three (3) months, in accordance with the Company’s normal payroll schedule and policy in effect from time to time. For purposes of this section, “Disability” shall mean your inability to perform your duties under
this Agreement because you have become permanently disabled within the meaning of any policy of disability income insurance covering employees of the Company then in force. In the event the Company has no policy of disability income insurance
covering employees of the Company in force when you become disabled, the term “Disability” shall mean your inability to perform your duties under this Agreement by reason of any incapacity, physical or mental, which the Board, based
upon medical advice or an opinion provided by a licensed physician acceptable to the Board, determines to have incapacitated you from satisfactorily performing all of your usual services for the Company for a period of at least ninety (90) days
during any twelve (12) month period (whether or not consecutive) and is expected to continue to incapacitate you thereafter, not including any time during which you were on medical leave required by federal or state law. Based upon such medical
advice or opinion, the determination of the Board shall be final and binding and the date such determination is made shall be the date of such Disability for purposes of this Agreement. 

(d)    Involuntary Termination. Subject to the provisions of Section 5 hereof, if your employment is
terminated by the Company other than for Cause or by you for Good Reason which shall also be deemed an involuntary termination by the Company then, as a severance benefit, the Company shall (a) continue to pay you an amount equal to one-twelfth (1/12th) of your Base Salary for twelve (12) months, (b) any pro-rated bonus earned to date per the Company’s Management Incentive Plan, and
(c) during the initial three-year employment term, accelerate the vesting of any of the RSUs and PSUs granted pursuant to Section 2(f) above as follows: i) for the percentage of shares equal to the number of months of full-time employment
as of the date of employment termination divided by thirty six (i.e., number of months of employment divided by 36), as well as, ii) the additional amount of 50% of all of your unvested (as of the date of termination of employment after the
acceleration granted in (i) above), RSUs and PSUs shall vest in full. 

  
 4 

 (e)    Definition of “Cause”. For purposes of this
Agreement, “Cause” shall mean any of the following: (i) acts of moral turpitude, fraud or dishonesty that involve the assets of the Company, its customers, suppliers or affiliates; (ii) the conviction of, or a pleading of
guilty or nolo contendere to, a felony other than involving a traffic related infraction; (iii) use of narcotics, liquor or illicit drugs in a manner that has had a detrimental effect on the performance of your duties;
(iv) willfully and repeatedly neglecting your duties to the Company; (v) engaging in any personal conduct which, after an investigation by a neutral third party law firm, is determined to be discriminatory or harassing toward other Company
employees; or (vi) engaging in any conduct which breaches a material provision of this Agreement or the Inventions Agreement (as defined below). 

(A)    Cause shall only exist where the Company has provided you with written notice of the alleged problem or violation
of this Agreement or the Inventions Agreement, and you shall have failed to cure such condition to the reasonable satisfaction of the Company within ten (10) business days. In making any determination that Cause exists, the Board shall act
fairly and in good faith and shall give you an opportunity to appear and be heard at a meeting of the Board or any committee thereof and present evidence on your behalf. For any termination pursuant to (e)(i), (e)(v) or (e)(vi) of Section 3,
the Company must have reasonable, specific evidence to establish that such conduct has occurred or “Cause” shall not exist. For the avoidance of doubt, and notwithstanding anything herein contained to the contrary, in the event that
(x) any of the conditions specified in Section (e)(i) through (e)(vi) of Section 3 shall have occurred, and (y) the Company has unimpeachable evidence to establish that such conduct has occurred, and (z) the conduct shall not be
of a nature that is capable of cure, then the Company shall not be required to provide you any cure period in respect thereof. 

(f)    “Good Reason” shall mean (A) a material reduction or diminution in your authority, duties,
responsibilities, title or position with the Company or any successor thereto without your consent, (B) a material breach by the Company of its contractual obligations to you, (C) a material reduction in your Base Salary of more than ten
percent (10%) or a material reduction in your benefits, without your written consent, other than a reduction in salary or benefits with respect to management-level employees of the Company generally, (D) the relocation, without your written
consent, of your principal workplace to a geographic location that is more than fifty (50) miles from the Company’s place of business in Burlington, Massachusetts, or (E) failure of any successor to the Company to assume and agree to
perform substantially all of the Company’s obligations pursuant to the terms and conditions of this Agreement. In order to resign for Good Reason, you must provide written notice to the Company within 30 days after the first occurrence of the
event giving rise to Good Reason setting forth the basis for your resignation, allow the Company at least 30 days from receipt of such written notice to cure such event, and if such event is not reasonably cured within such period, you must resign
from all positions you then hold with the Company not later than 90 days after the expiration of the cure period. 

4.    Mitigation. You shall not be required to mitigate the amount of any payment or benefits provided for in this
Agreement by seeking other employment or otherwise. Further, the amount of any payment or benefits provided for in this Agreement shall not be reduced by any compensation earned by you as a result of employment by another employer, by retirement
benefits, by offset against any amount claimed to be owed by you to the Company or otherwise. 

  
 5 

 5.    Conditions to Receipt of Severance or other Benefits Pursuant
to this Agreement. 
 (a)    Release of Claims Agreement. Notwithstanding anything herein contained to the
contrary, the receipt of any severance or other benefits pursuant to Section 3(d) of this Agreement (the “Separation Payments”) is subject to your signing and not revoking a separation agreement and release of claims, based on
the Company’s standard form release, of any and all claims you may have against the Company and its officers, employees, directors, parents and affiliates, in substantially the form attached hereto on Exhibit C (the
“Release”), which must become effective and irrevocable no later than the sixtieth (60th) day following the termination of employment (the “Release Deadline”). If
the Release does not become effective and irrevocable by the Release Deadline, you will forfeit any rights to Separation Payments or benefits under this Agreement. No Separation Payments and benefits under this Agreement will be paid or provided
until the Release becomes effective and irrevocable, and any such Separation Payments and benefits otherwise payable between the date of your termination of employment and the date the Release becomes effective and irrevocable will be paid on the
date the Release becomes effective and irrevocable. 
 (b)    Continued Compliance with Agreements. Provided that
the Company remains in compliance with its obligations then applicable following termination of the Agreement, your receipt of any Separation Payments or other benefits pursuant to this Agreement will be subject to and contingent upon your continued
compliance following the date of your termination with the terms of this Agreement then applicable, the Inventions Agreement and the Release, notwithstanding anything herein contained to the contrary. 

6.    Confidential and Proprietary Information. 

(a)    Confidential Information and Inventions Agreement. As a condition to the execution and effectiveness of this
Agreement, you agree to abide by, the Company’s Confidential Information and Inventions Agreement which you previously executed (the “Inventions Agreement”). In furtherance, and not in limitation of the provisions thereof, you
agree, during the term hereof and thereafter, that you shall take all steps reasonably necessary to hold the Company’s proprietary information in trust and confidence, will not use proprietary information in any manner or for any purpose except
in connection with the performance of your services to the Company, and will not (other than in the performance of the services to the Company as herein contemplated) disclose any such proprietary information to any third party without first
obtaining the Company’s express written consent on a case-by-case basis. 

(b)    Third Party Information. You understand that the Company has received, and will in the future receive, from
third parties confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and use it only for certain limited purposes (the “Third Party Information”). To
the extent consistent with the Company’s duties heretofore described, you agree to hold Third Party Information in confidence and not to disclose to anyone (other than the Company’s personnel who need to know such information in connection
with their work for the Company) or to use, except in connection with the performance of your services to the Company, Third Party Information unless expressly authorized in writing by an officer of the Company. 

  
 6 

 (c)    Whistleblower Exception. Notwithstanding any provision of
this Agreement to the contrary, including but not limited to this Section 6, you may report possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the
Securities and Exchange Commission, and any agency Inspector General, or make other disclosures that are protected under the whistleblower provisions of federal law or regulation. You do not need the prior authorization from the Company to make any
such reports or disclosures and you are not required to notify the Company that you have made such reports or disclosures. 

7.    Covenant Not to Compete. During the longer of (a) a period of two years beginning on the Commencement
Date, or (b) the duration of your employment with the Company plus two years following the termination thereof, you shall not, directly or indirectly (whether as an employer, operator, agent, independent contractor, consultant, owner, director,
officer, shareholder, investor, partner (general or limited), joint venturer or any other relationship or relationships similar to any of the foregoing), anywhere in the world do the following: 

(a)    Restriction on Competitive Activities. Engage in any activities, perform any services or conduct, have an
interest in or participate in any businesses that are competitive with any part of the business of the Company, whether as currently conducted or as currently planned to be conducted, providing critical event management software as a service
(including mass notification, IT alerting, IoT alerting, risk data collection and analysis, crisis management, and related applications) plus any other business in which the Company makes a substantial future investment and is generating revenue
(collectively, the “Business”), including without limitation, develop, create, license, sell, distribute or otherwise commercially exploit any product, service or methodology that has the same principal function or features as the
Company’s proprietary software products and related services that constitute the Business. 
 (b)    No
Solicitation of Customers. Solicit or divert away or attempt to solicit or divert away any customer of the Company in an effort to provide products or services to such customer which are competitive with the Business. 

(c)    Restrictions on Relationships Involving Competitive Activities. Be engaged by, employed by, consult with,
own any capital stock of, or have any financial interest of any kind in, any individual, person or entity, which conducts a business that is competitive with any part of the Business. Notwithstanding the preceding sentence, you may own, for
investment purposes only, up to 1% in the aggregate of the outstanding stock or other equity interest of any entity that is competitive with the Business. 

8.    Covenant Not to Solicit. During the longer of (a) a period of one year beginning on the Commencement
Date, or (b) the duration of your employment with the Company plus one year following the termination thereof, you shall not, directly or indirectly (whether as an employer, operator, agent, independent contractor, consultant, owner, director,
officer, shareholder, investor, partner (general or limited), joint venturer or any other relationship or relationships similar to any of the foregoing), anywhere in the world do the following: 

  
 7 

 (a)    Restrictions on Relationships Involving Solicitation.
Cause, induce, solicit, recruit, hire or encourage or attempt to cause, induce, solicit, recruit, hire or encourage any person or entity that prior to the date hereof was an employee, subcontractor, contractor, agent, distributor, licensee, licensor
or supplier of the Company to terminate, or otherwise change in any manner adverse to the Company or any of its affiliates, its relationship with the Company, or, hire or attempt to hire any person employed by the Company or any of its affiliates,
provided that you may hire such employee if such employee’s employment with the Company or any of its affiliates has been terminated prior to date of hire by you. 

9.    Arbitration. 

(a)    Agreement to Arbitrate. Except as provided for any action arising out of any violation of the Inventions
Agreement or as set forth in clause (b) below addressing excluded claims and remedies, you and the Company both agree that any disputes of any kind whatsoever arising out of or relating to the termination of your employment with the Company,
including any breach of this Agreement, shall be subject to final and binding arbitration. 
 (b)    Excluded Claims,
Relief and Enforcement. You understand that this Agreement does not prohibit you from pursuing an administrative claim with a local, state, or federal administrative body such as the Department of Fair Employment and Housing, the Equal
Employment Opportunity Commission, the National Labor Relations Board, or the Workers’ Compensation Board, or the Department of Unemployment Assistance for unemployment benefits. This Agreement does not preclude the Company or you from pursuing
court action regarding any claims arising out of any breach of the Inventions Agreement or other claims not otherwise resulting from, or arising out of, the termination of your employment with the Company. Nothing in this Agreement prohibits either
party from seeking injunctive or declaratory relief from a court of competent jurisdiction. Either the Company or you may bring an action in court to compel arbitration under this Agreement and to enforce an arbitration award. Otherwise, with the
exception of claims set forth in this clause or arising out of the Inventions Agreement, or which are asserted in any court or administrative action as an affirmative defense, counterclaim, cross-claim, third party or other claim, neither party
shall initiate or prosecute any lawsuit or claim in anyway related to any arbitrable claim, including without limitation any claims as to the making, existence, validity, or enforceability of the agreement to arbitrate. 

(c)    Procedure. You agree that any arbitration will be administered by Judicial Arbitration & Mediation
Services, Inc. (“JAMS”), pursuant to its employment arbitration rules and procedures (the “JAMS Rules”), which are available at www.jamsadr.com/rules-employment-arbitration. A neutral and impartial arbitrator shall
have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers, and motions related to discovery, prior to any arbitration hearing. You also
agree that the arbitrator shall have the power to award any remedies available under applicable law. In the event that either party to this Agreement rejects a written offer to compromise from the other party, and fails to obtain a more favorable
judgment or award, the arbitrator may award attorneys’ fees and 

  
 8 

 
costs to the party that made the offer to compromise in an amount that the arbitrator deems appropriate, taking into consideration the attorneys’ fees and costs (including expert fees)
actually incurred and reasonably necessary to defend or prosecute the action. The arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy, and the arbitrator shall not order or require the Company to adopt
a policy not otherwise required by law. You understand that the Company will pay the costs and fees of the arbitration that you initiate, but only those fees over and above the costs you would have incurred had you filed a complaint in a court of
law. You and the Company agree that the arbitrator shall prepare a written decision containing the essential findings and conclusions on which the award is based. You and the Company agree that any arbitration under this Agreement shall be conducted
in Boston, Massachusetts. 
 (d)    Exclusive and Final Remedy. Except as provided by the JAMS Rules and this
Agreement, arbitration shall be the sole, exclusive and final remedy for any dispute between you and the Company. Accordingly, except as provided for by the JAMS Rules and this Agreement, neither you nor the Company will be permitted to pursue court
action regarding claims that are subject to arbitration. Nothing in this Agreement or in this provision is intended to waive the provisional relief remedies available under the JAMS Rules. 

(e)    Prohibition of Group Actions. Claims must be brought in your individual capacity, not as a representative or
class member in any purported class or representative proceeding. The arbitrator shall not consolidate claims of different employees into one proceeding, nor shall the arbitrator have the power to hear arbitration as a class action. 

(f)    Voluntary Nature of Agreement. You acknowledge and agree that you are executing this Agreement voluntarily
and without any duress or undue influence by the Company or anyone else. You further acknowledge and agree that you have carefully read this Agreement and have asked any questions needed for you to understand the terms, consequences, and binding
effect of this Agreement and fully understand it, including that you are waiving your right to a jury trial. Finally, you acknowledge that you have been advised by the Company to seek the advice of an attorney of your choice before
signing this Agreement and you agree that you have been provided such an opportunity. 
 10.    General. 

(a)    Entire Agreement, Amendment and Waiver. This Agreement, together with the other agreements specifically
referred to herein, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof,
including but not limited to the offer letter between you and the Company dated May 16, 2019. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by the parties hereto. The terms and
provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. Each such waiver or consent will be effective only in
the specific instance and for the purpose for which it was given, and will not constitute a continuing waiver or consent. 

  
 9 

 (b)    Notices. Any notice, request, instruction or other
document required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) three (3) days after having been sent by registered or certified mail, return
receipt requested, postage prepaid; or (c) one (1) business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the party to
be notified at the following address of such party or at such other address as such party may designate by ten (10) days advance written notice to the other parties hereto in accordance with the provisions hereof: 

 

							
	                	 	If to the Company:            	  	Everbridge, Inc.	  	
		 		  	25 Corporate Drive	  	
		 		  	Burlington, MA 01803	  	
		 		  	Attention: Chairman	  	
				
		 	with a copy to:	  	Everbridge, Inc.	  	
		 		  	25 Corporate Drive	  	
		 		  	Burlington, MA 01803	  	
		 		  	Attention: General Counsel	  	
				
		 	If to you:	  	David Meredith	  	
		 		  	[ADDRESS]	  	

 (c)    Availability of Injunctive Relief. The parties hereto agree that,
notwithstanding anything to the contrary herein contained, any party may petition a court for injunctive relief where either party alleges or claims a violation of this Agreement or the Inventions Agreement or any other agreement regarding trade
secrets, confidential information, noncompetition, non-solicitation or assignment of inventions. In the event either party seeks injunctive relief, the prevailing party shall be entitled to recover reasonable
costs and attorney’s fees. 
 (d)    Assignment. The Company may assign its rights and obligations hereunder
to any person or entity that succeeds to all or substantially all of the Company’s business or that aspect of the Company’s business in which you are principally involved. You may not assign your rights and obligations under this Agreement
without the prior written consent of the Company. 
 (e)    Governing Law. This Agreement, and the rights and
obligations of the parties hereunder, will be construed in accordance with and governed by the law of the Commonwealth of Massachusetts, without giving effect to the conflict of law principles thereof. 

(f)    Taxes. All payments to you under this Agreement shall be subject to all applicable federal, state and local
withholding, payroll and other taxes. 
 (g)    Severability. The finding by an arbitrator or a court of
competent jurisdiction of the unenforceability, invalidity or illegality of any provision of this Agreement shall not render any other provision of this Agreement unenforceable, invalid or illegal. Such arbitrator or court shall have the authority
to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision which most accurately represents the parties’ intention with respect to the invalid or unenforceable term or provision. If
moreover, any one or more of the provisions contained in this Agreement will for any reason be held to be excessively broad as to duration, geographic scope, activity or subject, it will be construed by limiting and reducing it, so as to be
enforceable to the extent compatible with the applicable law as it will then appear. 

  
 10 

 (h)    Interpretation; Construction. The headings set forth in
this Agreement are for convenience of reference only and shall not be used in interpreting this Agreement. This Agreement has been drafted by legal counsel to the Company, but you have been encouraged to consult with, and have consulted with, your
own independent counsel and tax advisors with respect to the terms of this Agreement. The parties acknowledge that each party and its counsel has reviewed and revised, or had an opportunity to review and revise, this Agreement, and the normal rule
of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. 

(i)    Return of Company Property. Upon termination of this Agreement or earlier as requested by the Company, you
shall deliver to the Company any and all equipment, and, at the election of the Company, either deliver or destroy, and certify thereto, any and all drawings, notes, memoranda, specifications, devices, formulas and documents, together with all
copies, extracts and summaries thereof, and any other material containing or disclosing any Third Party Information or Proprietary Information (as defined in the Inventions Agreement) of the Company. 

(j)    Survival. The provisions of Sections 3, 5, 6, 7, 8 and 9, and the provisions of the Inventions Agreement,
shall survive termination of this Agreement. 
 (k)    Representations and Warranties. By signing this Agreement,
you represent and warrant that (i) you are not restricted or prohibited, contractually or otherwise, from entering into and performing each of the terms and covenants contained in this Agreement, and (ii) your execution and performance of
this Agreement shall not violate or breach any other agreements between you and any other person or entity, and (iii) you have provided the Company with copies of any written agreements presently in effect between you and any current or former
employer. You further represent and warrant that you will not, during the term hereof, enter into any oral or written agreement in conflict with any of the provisions of this Agreement, the agreements referenced herein and the Company’s
policies. 
 (l)    Confirmation of Employment Status. Prior to your first day of employment with the Company,
and as a condition to such employment, you shall provide the Company with documentation of your eligibility to work in the United States, as required by the Immigration and Reform and Control Act of 1986. 

(m)    Trade Secrets of Others. It is the understanding of both the Company and you that you shall not divulge to
the Company and/or its subsidiaries any confidential information or trade secrets belonging to others, including your former employers, nor shall the Company seek to elicit from you any such information. Consistent with the foregoing, you shall not
provide to the Company and/or its affiliates, and the Company and/or its affiliates shall not request, any documents or copies of documents containing such information. 

(n)    Telecopy Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be
executed by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on behalf of such party can be seen. Such execution and delivery shall be considered
valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any facsimile, telecopy or other reproduction hereof. 

(o)    Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed an original,
all of which together shall constitute one and the same instrument. 

  
 11 

 EVERBRIDGE, INC. 

Executive Employment Agreement — Counterpart Signature Page 

If the foregoing accurately sets forth our agreement, please so indicate by signing and returning to us the enclosed copy of
this letter. 
  

			
	Very truly yours,
	
	EVERBRIDGE, INC.
		
	By:	 	/s/ Jaime Ellertson
		
	Name:	 	Jaime Ellertson
		
	Title:	 	Chairman & CEO
		
	Date:	 	May 30, 2019

  

	
	ACCEPTED AND AGREED TO BY:
	
	/s/ David Meredith
	David Meredith
	May 25, 2019

  

  
 12 

 Schedule 1 

Duties and Responsibilities 
  

	 	•	 	 Define, in conjunction with the Board, the forward-looking vision and growth strategy for Everbridge and lead its
overall execution 

  

	 	•	 	 Be a visible presence for Everbridge in the market and generate positive exposure as a thought leader among
customers, partners, stakeholders, the media, analysts and the general public 

  

	 	•	 	 Maintain healthy and predictable Everbridge growth by establishing and consistently meeting execution milestones
related to the Company’s operating and financial plans 

  

	 	•	 	 Identify and capitalize on opportunities to accelerate Everbridge’s growth trajectory through people,
customer service, product innovation, strategic partnerships and M&A 

  

	 	•	 	 As necessary, refine the business model and
go-to-market strategies as Everbridge continues to evolve into new growth areas and further establishes itself as the global leader in the market 

 

	 	•	 	 Maintain a corporate culture at Everbridge that is a competitive advantage and visible to customers, partners and
employees 

  

	 	•	 	 Provide overall leadership in the organization, working across all aspects and functions of the business

 Exhibit A 

Everbridge, Inc. 
 2019
Management Incentive Plan 
 Introduction 
 The 2019
Management Incentive Plan (“The Plan”) is designed as an incentive to participants to perform at their most effective level, as a reward for strong performance and as a way of sharing in the success of the Company. The Plan is designed to
be self-funded and is incorporated in the business targets and budgets. 
 The Plan is one element of Everbridge’s total compensation package,
inclusive of base salary, equity, benefits and other variable compensation plans. The Plan is designed to reward high performance – corporate, team and individual. Awards payable under the Plan will be determined through a combination overall
bonus pool funding which will be based upon predefined corporate financial objectives and achievement of specific team and individual/development goals. 

This Plan is CONFIDENTIAL, and details may not be disclosed by any participants. 

Eligibility for Participation 
 Designated employees
(“Participants”) are eligible for inclusion in The Plan for the calendar year January 1, 2019 to December 31, 2019. Participation in The Plan is at the discretion of the Company. Employees considered for participation include
management level employees and individual contributors in functions who meet established criteria. Eligibility for participation is not automatic and will be reviewed annually. 

Participation for new hires designated as eligible to participate will be pro-rated based on days in The Plan during
the plan year. 
 There is no contractual commitment on the part of the Company in relation to future years of participation and in this respect the Plan
does not confer on any employees any rights to future participation, future employment, or give rise to any cause of action against the Company. 

Operation of The Plan 
 For each Participant a fixed cash
amount will be specified for the purposes of participation in The Plan. The overall Plan funding will be based on the achievement of corporate targets and/or business unit/departmental business plans. Individual bonus achievement will be based upon
achievement of team, individual and development-based performance goals as agreed to by you and your manager and maintained within Reflektive. A copy of the business plan will be on file with the Human Resources Department and each participant will
be provided a copy. 
 Each participant must sign a copy of The Plan document acknowledging that the document was reviewed. 

Everbridge management reserves the right to modify the Plan at any time. Notification of changes to the Plan will be made in writing to affected participants.
Changes may be made to the Plan periodically in order to revise goals, update strategies or correct errors. 
 Performance against business targets will be
assessed at the end of the fiscal year once all financial results of the Company have been prepared and approved. Everbridge management will have the discretion to adjust, up or down, any employee’s payout based on subjective assessment of the
employee’s individual performance throughout the year. Any adjustment to individual bonus target will not increase the overall bonus pool funding relative to the level of achievement of the Company. 

 All metrics will be measured independently. For most Plan elements, a minimum threshold between 85-90% must be achieved for each element to be qualified for payout. If any individual element is not achieved, other elements of the plan may still payout, if the requisite minimum threshold is met. 

Payment 
 Bonus payments will be made annually after the
official close of the operating year, estimated to occur no later than May of the year following. Payment will be made to each participant provided that the participant: 
  

	 	•	 	 Has not given notice to resign employment before any payment is made, and 

 

	 	•	 	 Remains an active employee at the time of payout. 

Any payment to which participants in the following categories may be entitled will be pro-rated: 

 

	 	•	 	 Employees whose eligibility for participation in The Plan begins after January 1, 2019, or

  

	 	•	 	 Employees who are transferred to another position, business unit, department or group within the Company during
the plan year and their new position does not qualify them as eligible to participate in The Plan. 

  

	 	•	 	 Employees who transfer to a position and become eligible to participate in the Plan during the plan year.

 Any payment in whole or in part shall be made through the Company’s normal payroll process and will be net of any appropriate
Income Tax, Social Security Contributions or other relevant deductions. 
 The Chief Executive Officer and Board of Directors of Everbridge, Inc.
reserves the right to amend the plan at any time based on business conditions. 
 Contractual Status 

Payments under The Plan are not contractual. No legally enforceable right to payment will arise under The Plan, nor any right to compensation or damages for non-payment as a result of the termination of employment (however caused), or for any other reason. 
 The Plan is not a
guarantee of employment for a definite period of time. The participant acknowledges and understands that she or he, or Everbridge, may terminate the employment relationship at any time with or without cause. 

The Plan terminates, for the participant, on the date the participant’s employment with Everbridge is terminated. 

This Plan shall be construed and governed in accordance with the laws of the Commonwealth of Massachusetts. 

Validity 
 The Plan is valid only for the calendar year
January 1, 2019 – December 31, 2019. At the expiration of this Plan, Everbridge will establish a new Plan for Participants. 

 Exhibit B 

Vesting Schedule 
 At the end of the
fiscal quarter ended immediately after the second anniversary of the Grant Date (the “First Measurement Date”), up to sixty-two and one-half
percent (62.5%) of the Shares subject to this Award will become eligible to vest based on the compound annual growth rate (the “CAGR”) achieved during the eight fiscal quarters preceding the most recent fiscal quarter. At the
end of the fiscal quarter ended immediately after the third anniversary of the Grant Date (the “Second Measurement Date”), up to an additional sixty-two and one-half percent (62.5%) of the Shares subject to this Award will become eligible to vest based on the CAGR achieved during the twelve fiscal quarters preceding the most recent fiscal quarter. In each case, the CAGR
shall be determined based on the Company’s consolidated revenue during each such quarter, as reported in the Company’s consolidated financial statements. Any such vesting will take place on the date that the Company files its Form 10-Q or Form 10-K for the applicable Measurement Date. The number of shares vested as of either measurement date shall be determined with reference to the following table:

  

					
	 REVENUE GROWTH
	  	 PSU VESTING
	  	 LINEAR INTERPOLATION VESTING

	 <20%
	  	0%	  	No linear interpolation vesting
	 20% to 25%
	  	5% to 12.5%	  	1.5% increased vesting for every 1% above 20%
	 25% to 30%
	  	12.5% to 25%	  	2.5% increased vesting for every 1% above 25%
	 30% to 35%
	  	25% to 50%	  	5% increased vesting for every 1% above 30%
	 40%
	  	62.5%	  	Cliff vesting of added 12.5% of PSUs (no linear vesting)

 For the avoidance of doubt, only up to 62.5% of the Shares may vest on either the First Measurement Date or the Second
Measurement Date. The PSUs shall expire with respect to any Shares not vested as of the Second Measurement Date. 

 Exhibit C 

Form of Release Agreement 
 This Release
Agreement (“Release” or “Agreement”) is made by and between ___________________ (“you”) and Everbridge, Inc. (the “Company”). A copy
of this Release is an attachment to the Employment Agreement between the Company and you dated _________________ _______, 20___ (the “Employment Agreement”). Capitalized terms not defined in this Agreement carry the
definition found in the Employment Agreement. 
 1.    Separation Payments. In consideration for your
execution, return and non-revocation of this Release on or after the date your employment is terminated (the “Separation Date”), the Company will provide you with the Separation
Payments described in Section 3(d) of the Employment Agreement: 
 2.    Compliance with
Section 409A. The Separation Payments offered to you by the Company are payable in reliance on Treasury Regulation Section 1.409A-1(b)(9) and the short term deferral exemption in
Treasury Regulation Section 1.409A-1(b)(4). For purposes of Code Section 409A, your right to receive any installment payments (whether pay in lieu of notice, Separation Payments, reimbursements or
otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment shall at all times be considered a separate and distinct payment. All payments and benefits are subject to
applicable withholdings and deductions. 
 3.    Release. In exchange for the Separation Payments and
other consideration, to which you would not otherwise be entitled, and except as otherwise set forth in this Agreement, you, on behalf of yourself and, to the extent permitted by law, on behalf of your spouse, heirs, executors, administrators,
assigns, insurers, attorneys and other persons or entities, acting or purporting to act on your behalf (collectively, the “Employee Parties”), hereby generally and completely release, acquit and forever discharge the Company,
its parents and subsidiaries, and its and their officers, directors, managers, partners, agents, representatives, employees, attorneys, shareholders, predecessors, successors, assigns, insurers and affiliates (the “Company
Parties”) of and from any and all claims, liabilities, demands, contentions, actions, causes of action, suits, costs, expenses, attorneys’ fees, damages, indemnities, debts, judgments, levies, executions and obligations of every
kind and nature, in law, equity, or otherwise, both known and unknown, suspected and unsuspected, disclosed and undisclosed, arising out of or in any way related to agreements, events, acts or conduct at any time prior to and including the execution
date of this Agreement, including but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with your employment with the Company or the termination of that employment; claims or demands related to
salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; claims pursuant to any federal, state or
local law, statute, or cause of action; tort law; or contract law (individually a “Claim” and collectively “Claims”). The Claims you are releasing and waiving in this Agreement include, but are not
limited to, any and all Claims that any of the Company Parties: 
  

	 	•	 	 has violated its personnel policies, handbooks, contracts of employment, or covenants of good faith and fair
dealing; 

  

	 	•	 	 has discriminated against you on the basis of age, race, color, sex (including sexual harassment), national
origin, ancestry, disability, religion, sexual orientation, marital status, parental status, source of income, entitlement to benefits, any union activities or other protected category in violation of any local, state or federal law, constitution,
ordinance, or regulation, including but not limited to: the Age Discrimination in Employment Act, as amended (“ADEA”); Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; 42 U.S.C.
§ 1981, as amended; the Equal Pay Act; the Americans With Disabilities Act; the Genetic Information Nondiscrimination Act; the Family and Medical Leave Act; the Massachusetts Fair Employment Practices Act; the Massachusetts Civil Rights
Act; the Massachusetts Equal Rights Act; the Massachusetts Labor and Industries Act; the Massachusetts Privacy Act; the Massachusetts Maternity Leave Act; the Massachusetts Small Necessities Leave Act; the Employee Retirement Income Security Act;
the Employee Polygraph Protection Act; the Worker Adjustment and Retraining Notification Act; the Older Workers Benefit Protection Act; the anti-retaliation provisions of the Sarbanes-Oxley Act, or any other federal or state law regarding
whistleblower retaliation; the Lilly Ledbetter Fair Pay Act; the Uniformed Services Employment and Reemployment Rights Act; the Fair Credit Reporting Act; and the National Labor Relations Act; and 

	 	•	 	 has violated any statute, public policy or common law (including, but not limited to, Claims for retaliatory
discharge; negligent hiring, retention or supervision; defamation; intentional or negligent infliction of emotional distress and/or mental anguish; intentional interference with contract; negligence; detrimental reliance; loss of consortium to you
or any member of your family and/or promissory estoppel). 

 Notwithstanding the foregoing, other than events expressly contemplated by
this Agreement you do not waive or release rights or Claims that may arise from events that occur after the date this Release is executed. Also excluded from this Agreement are any Claims which cannot be waived by law, including, without limitation,
any rights you may have under applicable workers’ compensation laws. Nothing in this Agreement shall prevent you from filing, cooperating with, or participating in any proceeding or investigation before the Equal Employment Opportunity
Commission, United States Department of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal government agency, or similar state or local agency
(“Government Agencies”), or exercising any rights pursuant to Section 7 of the National Labor Relations Act. You further understand this Agreement does not limit your ability to voluntarily communicate with any
Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Agreement does not limit
your right to receive an award for information provided to the Securities and Exchange Commission, you understand and agree that, you are otherwise waiving, to the fullest extent permitted by law, any and all rights you may have to individual relief
based on any Claims that you have released and any rights you have waived by signing this Agreement. If any Claim is not subject to release, to the extent permitted by law, you waive any right or ability to be a class or collective action
representative or to otherwise participate in any putative or certified class, collective or multi-party action or proceeding based on such a Claim in which any of the Company Parties is a party. This Agreement does not abrogate your existing
rights under any Company benefit plan or any plan or agreement related to equity ownership in the Company; however, it does waive, release and forever discharge Claims existing as of the date you execute this Agreement pursuant to any such plan or
agreement. 
 4.    Your Acknowledgments and Affirmations. You also acknowledge and agree that
(i) the consideration given to you in exchange for the waiver and release in this Agreement is in addition to anything of value to which you were already entitled, and (ii) that you have been paid for all time worked, have received all the
leave, leaves of absence and leave benefits and protections for which you are eligible, and have not suffered any on-the-job injury for which you have not already filed
a Claim. You affirm that all of the decisions of the Company Parties regarding your pay and benefits through the date of your execution of this Agreement were not discriminatory based on age, disability, race, color, sex, religion, national origin
or any other classification protected by law. You affirm that you have not filed or caused to be filed, and are not presently a party to, a Claim against any of the Company Parties. You further affirm that you have no known workplace injuries or
occupational diseases. You acknowledge and affirm that you have not been retaliated against for reporting any allegation of corporate fraud or other wrongdoing by any of the Company Parties, or for exercising any rights protected by law, including
any rights protected by the Fair Labor Standards Act, the Family Medical Leave Act or any related statute or local leave or disability accommodation laws, or any applicable state workers’ compensation law. 

In addition, you acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA
(“ADEA Waiver”). You also acknowledge that the consideration given for the ADEA Waiver is in addition to anything of value to which you were already entitled. You further acknowledge that you have been advised by this
writing, as required by the ADEA, that: (a) your release and waiver herein does not apply to any rights or claims that arise after the date you sign this Agreement; (b) you should consult with an attorney prior
to signing this Agreement; (c) you have twenty-one (21) days to consider this Agreement (although you may choose to voluntarily sign it sooner); (d) you have seven
(7) days following the date you sign this Agreement to revoke it (by sending written revocation directly to the Company’s [title]); and (e) the Agreement will not be effective until the
date upon which the revocation period has expired unexercised, which will be the eighth day after you sign this Agreement. 

5.    Return of Company Property. By the Separation Date, you agree to return to the Company all Company documents
(and all copies thereof) and other Company property that you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications,
computer-recorded information, tangible property (including, but not limited to, computers), credit cards, entry cards, identification badges and keys; and, any materials of any kind that contain or embody any proprietary or confidential information
of the Company (and all reproductions thereof). Please coordinate return of Company property with [name/title]. Receipt of the Separation Payments described in Section 1 of this Agreement is expressly conditioned upon return of all
Company property. 

 6.    Confidential Information,
Non-Competition and Non-Solicitation Obligations. Both during and after your employment you acknowledge your continuing obligations under your Confidential
Information and Inventions Agreement not to use or disclose any confidential or proprietary information of the Company and comply with your post-employment non-competition and
non-solicitation restrictions. The Company acknowledges that you will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is
made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a
complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, in the event that you file a lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the
trade secret to your attorney and use the trade secret information in the court proceeding, if you: (A) file any document containing the trade secret under seal; and (B) do not disclose the trade secret, except pursuant to court order.

 7.    Confidentiality. The provisions of this Agreement will be held in strictest confidence by you and
will not be publicized or disclosed in any manner whatsoever; provided, however, that: (a) you may disclose this Agreement to your immediate family; (b) you may disclose this Agreement in confidence to your attorney, accountant, auditor,
tax preparer, and financial advisor; and (c) you may disclose this Agreement insofar as such disclosure may be required by law. Notwithstanding the foregoing, nothing in this Agreement shall limit your right to discuss your employment with the
Equal Employment Opportunity Commission, United States Department of Labor, the National Labor Relations Board, other federal government agency or similar state or local agency or to discuss the terms and conditions of your employment with others to
the extent expressly permitted by Section 7 of the National Labor Relations Act. 
 8.    Non-Disparagement. You agree not to disparage the Company, and the Company’s attorneys, directors, managers, partners, employees, agents and affiliates, in any manner likely to be harmful to them or their
business, business reputation or personal reputation; provided that you will respond accurately and fully to any question, inquiry or request for information when required by legal process. Notwithstanding the foregoing, nothing in this Agreement
shall limit your right to voluntarily communicate with the Equal Employment Opportunity Commission, United States Department of Labor, the National Labor Relations Board, other federal government agency or similar state or local agency or to discuss
the terms and conditions of your employment with others to the extent expressly permitted by Section 7 of the National Labor Relations Act. 

9.    No Admission. This Agreement does not constitute an admission by the Company of any wrongful action or
violation of any federal, state, or local statute, or common law rights, including those relating to the provisions of any law or statute concerning employment actions, or of any other possible or claimed violation of law or rights. 

10.    Breach. You agree that upon any breach of this Agreement you will forfeit all amounts paid or owing
to you under this Agreement. Further, you acknowledge that it may be impossible to assess the damages caused by your violation of the terms of Sections 5, 6, 7 and 8 of this Agreement and further agree that any threatened or actual violation or
breach of those Sections of this Agreement will constitute immediate and irreparable injury to the Company. You therefore agree that any such breach of this Agreement is a material breach of this Agreement, and, in addition to any and all other
damages and remedies available to the Company upon your breach of this Agreement, the Company shall be entitled to an injunction to prevent you from violating or breaching this Agreement. 

11.    Miscellaneous. This Agreement constitutes the complete, final and exclusive embodiment of the entire
agreement between you and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises,
warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of
both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not
affect any other provision of this Agreement and the provision in question will be modified by the court so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with
the laws of the Commonwealth of Massachusetts as applied to contracts made and to be performed entirely within Massachusetts. 

			
	EVERBRIDGE, INC.
		
	By:	 	 
		 	[insert]
		
		 	 
		 	[insert]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]